NYSE:AVTR - New York Stock Exchange, Inc. - US05352A1007 - Common Stock - Currency: USD
AVANTOR INC
NYSE:AVTR (1/31/2025, 8:12:20 PM)
After market: 22.3 +0.02 (+0.09%)22.28
+0.06 (+0.27%)
The current stock price of AVTR is 22.28 USD. In the past month the price increased by 5.74%. In the past year, price decreased by -4.87%.
/PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...
/PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...
/PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...
/PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 27.34 | 228.64B | ||
DHR | DANAHER CORP | 29.74 | 160.88B | ||
A | AGILENT TECHNOLOGIES INC | 28.64 | 43.21B | ||
IQV | IQVIA HOLDINGS INC | 18.54 | 36.55B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 35.77 | 28.79B | ||
WST | WEST PHARMACEUTICAL SERVICES | 50.53 | 24.74B | ||
WAT | WATERS CORP | 36.48 | 24.67B | ||
ILMN | ILLUMINA INC | 76.73 | 21.05B | ||
ICLR | ICON PLC | 14.19 | 16.44B | ||
RVTY | REVVITY INC | 26.67 | 15.35B | ||
TECH | BIO-TECHNE CORP | 41.09 | 11.69B | ||
MEDP | MEDPACE HOLDINGS INC | 30.57 | 10.85B |
Avantor, Inc. engages in providing mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company is headquartered in Radnor, Pennsylvania and currently employs 14,500 full-time employees. The company went IPO on 2019-05-17. Its segments include Laboratory Solutions and Bioscience Production. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits, and peristaltic pumps. Equipment and instrumentation include filtration systems, virus inactivation systems, analytical instruments, freezers, and biological safety cabinets. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
AVANTOR INC
Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road
Radnor PENNSYLVANIA 19087 US
CEO: Michael Stubblefield
Employees: 14500
Company Website: https://www.avantorsciences.com/
Investor Relations: https://ir.avantorsciences.com
Phone: 16103861700
The current stock price of AVTR is 22.28 USD.
The exchange symbol of AVANTOR INC is AVTR and it is listed on the New York Stock Exchange, Inc. exchange.
AVTR stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for AVTR, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of AVTR.
AVTR does not pay a dividend.
AVTR will report earnings on 2025-02-07, after the market close.
The PE ratio for AVTR is 22.73. This is based on the reported non-GAAP earnings per share of 0.98 and the current share price of 22.28 USD.
The outstanding short interest for AVTR is 4.5% of its float.
ChartMill assigns a technical rating of 3 / 10 to AVTR. When comparing the yearly performance of all stocks, AVTR is a bad performer in the overall market: 69.64% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to AVTR. There are concerns on the financial health of AVTR while its profitability can be described as average.
Over the last trailing twelve months AVTR reported a non-GAAP Earnings per Share(EPS) of 0.98. The EPS increased by -14.04% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.54% | ||
ROA | 2.41% | ||
ROE | 5.58% | ||
Debt/Equity | 0.84 |
ChartMill assigns a Buy % Consensus number of 78% to AVTR. The Buy consensus is the average rating of analysts ratings from 30 analysts.
For the next year, analysts expect an EPS growth of -6.37% and a revenue growth -1.92% for AVTR